HYSEN INC

FDA Device Registration & Listing · Cincinnati, OH, US · Registration 3036649420

Public Record Device Listing Expiry Year: 2026 This page presents structured fields from public FDA datasets.

Registration Header Parameters

Normalized identity and public registration information from FDA records.

Source
FDA Device Registration & Listing
Record Type
Device registration/listing
Registration Number
3036649420
FEI Number
3036649420
Entity Name
HYSEN INC
City/State/Country
Cincinnati, OH, US
Establishment Address
201 E 5th St Ste 1900, Cincinnati, OH 45202, US
Establishment Type(s)
Repack or Relabel Medical Device
Owner / Operator
Hysen Inc (Owner Number: 10092937)
Owner / Operator Contact Address
201 E Fifth Street, Suite 1900, Cincinnati, OH 45202, US
Initial Importer Flag
N
Expiration Date (Year)
2026
510(k) Number
PMA Number
N/A

All Registered Proprietary Names

UCP COMPACT DRUG TEST CUPS UCP COMPACT DRUG TEST CARDS Assure Tech. (Hangzhou) Co., Ltd DOA CUP Assure Tech. (Hangzhou) Co., Ltd DOA CARDS

Registered Product Listings

Product Code Device Name Medical Specialty Device Class Regulation Number Created Date
DIS Enzyme Immunoassay, Barbiturate Clinical Toxicology Class 2 862.3150 2025-06-27
DKZ Enzyme Immunoassay, Amphetamine Clinical Toxicology Class 2 862.3100 2025-06-27
LCM Enzyme Immunoassay, Phencyclidine Unknown Class U N/A 2025-06-27
DJC Thin Layer Chromatography, Methamphetamine Clinical Toxicology Class 2 862.3610 2025-06-27
DJR Enzyme Immunoassay, Methadone Clinical Toxicology Class 2 862.3620 2025-06-27
JXN Enzyme Immunoassay, Propoxyphene Clinical Toxicology Class 2 862.3700 2025-06-27
LDJ Enzyme Immunoassay, Cannabinoids Clinical Toxicology Class 2 862.3870 2025-06-27
JXM Enzyme Immunoassay, Benzodiazepine Clinical Toxicology Class 2 862.3170 2025-06-27
DJG Enzyme Immunoassay, Opiates Clinical Toxicology Class 2 862.3650 2025-06-27
DIO Enzyme Immunoassay, Cocaine And Cocaine Metabolites Clinical Toxicology Class 2 862.3250 2025-06-27
LFG Radioimmunoassay, Tricyclic Antidepressant Drugs Clinical Toxicology Class 2 862.3910 2025-06-27
NFY Test, Cocaine And Cocaine Metabolites, Over The Counter Clinical Toxicology Class 2 862.3250 2026-01-14
NFT Test, Amphetamine, Over The Counter Clinical Toxicology Class 2 862.3100 2026-01-14
NGM Test, Phencyclidine (Pcp), Over The Counter Unknown Class U N/A 2026-01-14
NGG Test, Methamphetamine, Over The Counter Clinical Toxicology Class 2 862.3610 2026-01-14
NGL Test, Opiates, Over The Counter Clinical Toxicology Class 2 862.3650 2026-01-14
NFV Test, Benzodiazepine, Over The Counter Clinical Toxicology Class 2 862.3170 2026-01-14
QBF Test, Propoxyphene, Over The Counter Clinical Toxicology Class 2 862.3700 2026-01-14
PTG Test, Methadone, Over The Counter Clinical Toxicology Class 2 862.3620 2026-01-14
NFW Test, Cannabinoid, Over The Counter Clinical Toxicology Class 2 862.3870 2026-01-14
QAW Test, Tricyclic Antidepressants, Over The Counter Clinical Toxicology Class 2 862.3910 2026-01-14
PTH Test, Barbiturate, Over The Counter Clinical Toxicology Class 2 862.3150 2026-01-14

Official Correspondent

Song Han

US Agent Details

No US Agent registered (Local establishment).

Related Public Records

Same Entity

Hysen Inc
View consolidated registration, premarket clearance, and recall records for this applicant.
View Entity Profile →

Related 510(k) Records

510(k) Number Applicant Device Name Decision Date
K833577 Syva Co. MODIF. OF EMIT URINE BARBITURATE 1984-01-26
K143535 Guangzhou Wondfo Biotech Co., Ltd. CR3 Keyless Split Sample Cup Secobarbital- Methadone 2015-01-13
K050024 Guangzhou Wondfo Biotech Co., Ltd. ONE STEP MULTIPLE DRUGS OF ABUSE ASSAYS 2005-11-17
K920417 Instrumentation Laboratory CO IL TEST BARBITURATE, 35289 1992-04-24
K970265 Drial Consultants, Inc. ONE STEP URINE DRUG OF ABUSE METHAMPHETAMINE TEST 1997-04-08

Related Recall Records

Recall ID Recalling Firm Recall Class Product Description
Z-2787-2018 Guangzhou Wondfo Biotech Co., Ltd. 2
TCube One Step Multi-Drug Oral Fluid Test Cube (AMPSO,COC20,METSO, OPl40,OXY20,THC2S) Product Usage: T-Cube One Step Multi-Drug Oral Fluid Test Cube is a rapid oral fluid screening test. The test is a lateral flow, one-step immunoassay for the qualitative detection of specific drugs and their metabolites in human oral fluid at the following cut off concentrations for use in employment and insurance testing. The assay provides a qualitative, preliminary test result. A more specific analytical method must be used in order to obtain a confirmed result. Gas Chromatography/Mass Spectrometry (GC/MS) or Liquid Chromatography/Tandem Mass Spectrometry (LC/MS-MS) are preferred confirmatory methods. Professional judgment should be applied to any drug test result, particularly when preliminary results are positive.
Z-2788-2018 Guangzhou Wondfo Biotech Co., Ltd. 2
TCube One Step Multi-Drug Oral Fluid Test Cube (AMPSO, BARGO, BZ030,COC20,MDMA100,METSO, MTD30,OPl40,OXY20, THC2S) Product Usage: T-Cube One Step Multi-Drug Oral Fluid Test Cube is a rapid oral fluid screening test. The test is a lateral flow, one-step immunoassay for the qualitative detection of specific drugs and their metabolites in human oral fluid at the following cut off concentrations for use in employment and insurance testing. The assay provides a qualitative, preliminary test result. A more specific analytical method must be used in order to obtain a confirmed result. Gas Chromatography/Mass Spectrometry (GC/MS) or Liquid Chromatography/Tandem Mass Spectrometry (LC/MS-MS) are preferred confirmatory methods. Professional judgment should be applied to any drug test result, particularly when preliminary results are positive.
Z-2789-2018 Guangzhou Wondfo Biotech Co., Ltd. 2
TCube One Step Multi-Drug Oral Fluid Test Cube (AMPSO, BARGO, SUPS, BZ030, COC20,MDMAlOO, METSO, OPl40,OXY20,THC2S) Product Usage: T-Cube One Step Multi-Drug Oral Fluid Test Cube is a rapid oral fluid screening test. The test is a lateral flow, one-step immunoassay for the qualitative detection of specific drugs and their metabolites in human oral fluid at the following cut off concentrations for use in employment and insurance testing. The assay provides a qualitative, preliminary test result. A more specific analytical method must be used in order to obtain a confirmed result. Gas Chromatography/Mass Spectrometry (GC/MS) or Liquid Chromatography/Tandem Mass Spectrometry (LC/MS-MS) are preferred confirmatory methods. Professional judgment should be applied to any drug test result, particularly when preliminary results are positive.
Z-0006-2010 Biosite Inc 2
Multi-Drug iCup Drug Screen Test Cup. Part Number DUD-1107-012-08A. Subsequent Product Codes: DIO, DIS, DJC, DJG, DJR, JXM, JXN, LCM, LDJ, LFG
Z-0007-2010 Biosite Inc 2
Multi-Drug 8 Panel Integrated iCup Drug Screen Test Cup. Part Number DUD-187-013-08A. Subsequent Product Codes: DIO, DIS, DJC, DJG, DJR, JXM, JXN, LCM, LDJ, LFG

Similar Registrations

Registration Number Establishment Name Location
3004987297 UCP BIOSCIENCES, INC. Milpitas, CA, US
1220972 MEDICA CORP. BEDFORD, MA, US
9610529 ROCHE DIAGNOSTICS GMBH PENZBERG Bavaria, DE
3008852306 Chemtron Biotech, Inc. San Diego, CA, US
2432235 Siemens Healthcare Diagnostics Inc. Tarrytown, NY, US
Source Citation & Summary: This public preview is extracted from openFDA device registration and listing logs under registration number 3036649420. Last updated year: 2026. Please use registration number 3036649420 when referencing this establishment in official correspondence.
Legal Disclaimer: AvaSpecs is not affiliated with the FDA or any government agency and does not provide medical, legal, regulatory, safety, approval, clearance, effectiveness, endorsement, or compliance advice. This index page is built using public record archives and does not represent an official regulatory determination.
Account Required Full available specs will require a free AvaSpecs account.